Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A WHO grade I, indolent and relatively circumscribed brain tumor. Morphologically it is characterized by the presence of astrocytes that line vascular and hyalinized pseudopapillae. In between the pseudopapillae aggregates of neurocytes, large neurons, and ganglioid cells are present.
Biomarker and diagnostic research for papillary glioneuronal tumor has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE4. Research is primarily industry-sponsored.
16 publications have been identified in PubMed for papillary glioneuronal tumor. Research spans Case Report / Case Series (31%), Review / Meta-Analysis (25%), and Other (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 31% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
4 |
25% |
Other research | 3 | 19% |
Laboratory research | 3 | 19% |
Testing and diagnosis research | 1 | 6% |
Wang Y (2026). [PMID: 42215018](https://pubmed.ncbi.nlm.nih.gov/42215018/). *J Neuropathol Exp Neurol*. [Basic Science / Preclinical]
Pelissier L (2026). [PMID: 41591436](https://pubmed.ncbi.nlm.nih.gov/41591436/). *Pediatr Radiol*. [Review / Meta-Analysis]
Gök H (2026). [PMID: 41660324](https://pubmed.ncbi.nlm.nih.gov/41660324/). *Surg Neurol Int*. [Case Report / Case Series]
Mezzacappa FM (2026). [PMID: 35015431](https://pubmed.ncbi.nlm.nih.gov/35015431/). *Unknown Journal*. [Review / Meta-Analysis]
Duan ZJ (2026). [PMID: 42252213](https://pubmed.ncbi.nlm.nih.gov/42252213/). *Zhonghua Bing Li Xue Za Zhi*. [Case Report / Case Series]
Hirata M (2025). [PMID: 40385825](https://pubmed.ncbi.nlm.nih.gov/40385825/). *Cureus*. [Case Report / Case Series]
Ragavendran C (2025). [PMID: 39891795](https://pubmed.ncbi.nlm.nih.gov/39891795/). *Neurosurg Rev*. [Diagnostic / Biomarker]
Mehrotra B (2025). [PMID: 38427744](https://pubmed.ncbi.nlm.nih.gov/38427744/). *Indian J Pathol Microbiol*. [Case Report / Case Series]
Huynh V (2025). [PMID: 41230946](https://pubmed.ncbi.nlm.nih.gov/41230946/). *J Neuropathol Exp Neurol*. [Basic Science / Preclinical]
Zhang Y (2025). [PMID: 40881872](https://pubmed.ncbi.nlm.nih.gov/40881872/). *Front Oncol*. [Case Report / Case Series]